Skip to main content
Find a DoctorGet Care Now
Skip to main content
Search icon magnifying glass

Contrast

Contact

Share

Donate

MyChart

Help

Image of Karin E Finberg

Karin E. Finberg, MD

Molecular Genetic Pathology, Pathology

Affiliated With: Yale Medicine

This doctor is not currently accepting new patients

This clinician is not accepting new patients at this time. If you are a current patient, please contact the office.

Locations

Yale Pathology New Haven, CT 06510

Biography - Karin E. Finberg, MD

Karin Finberg, MD, PhD, is a board-certified molecular genetic pathologist who specializes in using genetic sequencing techniques to characterize tumors from patients with cancer. Her clinical activities are performed in Yale New Haven Hospital's (YNHH) Tumor Profiling Laboratory.

“Our laboratory performs genetic analyses on a wide range of solid tumor types, including lung cancer, colorectal cancer, melanoma, and many others,” Dr. Finberg says. “In some cases, we are looking for specific genetic alterations in the tumor DNA that could make a patient eligible for a selected FDA-approved therapy that targets a particular genetic change. In other cases, we are evaluating the tumor DNA and RNA for a broader range of genetic abnormalities that might serve as entry criteria for clinical trials evaluating drugs that are being actively investigated.”

Dr. Finberg’s role is to review tumor testing results and to provide a clinical interpretation that will aid the referring oncologist in planning therapy for the patient. In addition to preparing pathology reports, she discusses tumor testing results with oncologists at the Yale Cancer Center's Precision Medicine Tumor Board, where molecular findings are considered in the context of each patient's individual clinical picture to help determine therapeutic options.

"There has been steady progress in the development of targeted therapies in recent years, and as a result, we have seen a large increase in tumor testing requests placed by oncologists," Dr. Finberg says. “By looking for a wide range of genetic changes in tumor specimens, we hope to increase our ability to match a patient to a clinical trial.”

Dr. Finberg divides her time between clinical work in the YNHH Tumor Profiling Laboratory and genetic-based laboratory research that investigates how the body handles iron, a metal that is essential for growth of normal cells, as well as for cancer cells.

At Yale School of Medicine, Dr. Finberg is an associate professor of pathology.

Read More

Overview

Gender

Female

Specialty

Molecular Genetic Pathology, Pathology

Conditions & Treatments

Hematologic Disorders, Hematology, Molecular Diagnostics, Molecular Pathology

Language(s)

English

Education & Training

Education

Yale College, Yale School of Medicine

Residency

Massachusetts General Hospital

Fellowship

Childrens Hospital Boston

Does this provider accept my Insurance?

YES! This insurance is accepted.

Sorry This insurance may not be accepted.

Accepted Insurance

Please check for your insurance on the list below.

  • AETNA
  • ANTHEM BC/BS
  • CIGNA GATEKEEPER PRO
  • CIGNA HEALTHCARE
  • COMMUNITY CARE NETWORK
  • COMPWORKS
  • CONNECTICARE
  • CONSUMER HEALTH NETWORK
  • CORVEL
  • FIRST HEALTH NETWORK
  • FOCUS HEALTHCARE
  • GREAT WEST
  • HEALTHCARE VALUE MANAGEMENT
  • HUMANA
  • HUSKY
  • MANAGED COMP
  • MEDICAID
  • MEDICARE
  • MULTIPLAN
  • OXFORD HEALTH PLANS
  • PREFERRED HEALTH WORKS
  • PRIME HEALTH SERVICES
  • PRIVATE HEALTHCARE SYSTEM (PHCS)
  • TRICARE - HEALTH NET FEDERAL
  • TRICARE/CHAMPUS
  • UNITED HEALTHCARE
  • WELLCARE

Insurance coverage regularly changes, please contact the doctor’s office directly to verify that your specific insurance plan is accepted.

More About Accepted Insurance

Locations

Map View

20 York Street
New Haven, CT 06510

Phone: (203) 785-5107
Fax: (203) 737-4626

Are you Karin E. Finberg, MD?

Update your profile